Who We Are

NorTwinCan (Nordic Twin Study of Cancer) is the largest twin study in the world available for the research of the heritability and familial risk of cancers such as prostate, breast, ovarian, and colon cancer.

Image Map Sweden Norway Finland Denmark
Sweden Sweden Norway Norway Harvard Harvard School of Public Health Finland Finland Denmark Denmark

Mission Statement

The NorTwinCan team seeks to more accurately quantify the heritable and familial risk of various cancers through the creation of a unique database that pools information from twin and cancer registers in four Nordic countries (Finland, Denmark, Sweden, and Norway). This is also meant to be a resource for internal and external investigators who are seeking to solve a myriad of other cancer-related mysteries.

Recent News

Manuscript published in JAMA

Manuscript published in JAMA

January 5, 2016

View All >